Nephrocare Health Services Limited reported a 23.5% year-on-year increase in consolidated revenue to Rs 303.4 crore for the second quarter ended...
Results · Finvezto · 3 Nov 2026 · Nephrocare Health Services (NEPHROPLUS)
Results ₹ Cr
| Latest quarter | ₹ Cr | QoQ | YoY |
|---|---|---|---|
| Revenue | 303 | - | +23.5% |
| Operating profit | 67 | - | - |
| Net profit | 34 | - | - |
| Operating margin | 22.1% | - | - |
| Net margin | 11.0% | - | - |
YoY is the company's own figure. QoQ shows where our quarterly series matches the filing.
Key points
- Nephrocare Health Services Limited reported a 23.5% year-on-year increase in consolidated revenue to Rs 303.4 crore for the second quarter ended September 30, 2026, with adjusted EBITDA rising 3.3% to Rs 68.9 crore and adjusted PAT growing 28.7% to Rs 39.3 crore. Network expansion reached 570 clinics across six countries... NSE filing
- Network expansion reached 570 clinics across six countries following entry into Kazakhstan, while quarterly dialysis treatments grew 12.0% year-on-year to 10,70,105. NSE filing
- Revenue was ₹303 Cr, up 23.5% on a year earlier. Finvezto data
Links
NSE filing (PDF) · Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.